| EILAX | OSMAX | EILAX / OSMAX | |
| Total Expense Ratio | 1.31 | 1.37 | 96% |
| Annual Report Gross Expense Ratio | 1.48 | 1.37 | 108% |
| Fund Existence | 10 years | 28 years | - |
| Gain YTD | 2.458 | 1.746 | 141% |
| Front Load | 5% | 6% | 95% |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.52M | 2.58B | 0% |
| Annual Yield % from dividends | 8.19 | 1.43 | 572% |
| Returns for 1 year | 23.51 | 2.65 | 886% |
| Returns for 3 years | 22.45 | -9.19 | -244% |
| Returns for 5 years | 5.11 | -32.79 | -16% |
| Returns for 10 years | 70.98 | 10.96 | 648% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| WSCGX | 35.57 | N/A | N/A |
| Allspring Small Company Growth Inst | |||
| VGIRX | 15.10 | -0.02 | -0.13% |
| Virtus Duff & Phelps Global Infras R6 | |||
| PHSTX | 63.67 | -0.12 | -0.19% |
| Putnam Global Health Care A | |||
| JGMRX | 23.02 | -0.09 | -0.39% |
| Janus Henderson Triton R | |||
| EEMFX | 10.55 | -0.06 | -0.57% |
| MFS Emerging Markets Equity Research R3 | |||